40 Years of the APOC Partnership.

PLoS Negl Trop Dis

World Bank, Washington, D.C., United States of America.

Published: May 2015

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431867PMC
http://dx.doi.org/10.1371/journal.pntd.0003562DOI Listing

Publication Analysis

Top Keywords

years apoc
4
apoc partnership
4
years
1
partnership
1

Similar Publications

Objective: Higher truncated-to-native apolipoprotein (apo) C-I proteoform ratios (C-I'/C-I) are associated with favorable cardiometabolic risk profiles, but their relationship with longitudinal changes in insulin resistance (IR) and incident diabetes is unknown.

Research Design And Methods: Plasma apoC-I proteoforms were measured by mass spectrometry immunoassay at baseline in 4,742 nondiabetic participants in the Multi-Ethnic Study of Atherosclerosis (MESA) and 524 participants with prediabetes in the Actos Now for Prevention of Diabetes (ACT NOW) study. The primary outcome was incident diabetes (fasting glucose [FG] ≥7.

View Article and Find Full Text PDF

The association between high-density lipoprotein (HDL) cholesterol and breast cancer (BC) remains controversial due to the high complexity of the HDL particle and its functionality. The HDL proteome was determined in newly diagnosed BC classified according to the molecular type [luminal A or B (LA or LB), HER2, and triple-negative (TN)] and clinical stage of the disease. Women (n = 141) aged between 18 and 80 years with BC, treatment-naïve, and healthy women [n = 103; control group (CT)], matched by age and body mass index, were included.

View Article and Find Full Text PDF

In recent years, novel apoC3 inhibitor therapies for the treatment of hypertriglyceridemia have been developed and assessed through phase II and III clinical trials. The objective of this study was to perform an updated meta-analysis on the impact of new apoC3 inhibitor drugs on triglyceride and apoC3 levels, as well as on the incidence of pancreatitis. We conducted a meta-analysis of randomized, placebo-controlled studies assessing the effects of apoC3 inhibitors therapy (antisense oligonucleotides and small interfering RNA) on triglyceride levels, apoC3 levels, and the occurrence of acute pancreatitis.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the relationship between different forms of Apolipoprotein C-III (apoC-III) and the risk of peripheral artery disease (PAD) in participants from a long-term study.
  • Researchers measured various apoC-III forms in over 5,700 participants and assessed their ankle-brachial index (ABI) at multiple points over 17 years.
  • They found that specific apoC-III proteoforms were associated with changes in ABI and a reduced risk of PAD, indicating that these proteoforms have unique effects on vascular health that aren't explained by total apoC-III levels alone.
View Article and Find Full Text PDF

Background: The way physical activity (PA) and sedentary behaviour (SB) independently and interactively modify the age-related decline in physical capacity remains poorly understood. This cross-sectional study investigated the independent and interactive associations of PA and SB with physical function and performance throughout the adult life course.

Methods: Data from 499 community-dwelling adults (63% female) aged 20-92 years, involved in the INSPIRE Human Translational Cohort, were used in this cross-sectional study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!